BioSpace News Archive

Veracyte, Inc. (“Veracyte”) (Nasdaq: VCYT) announced today that it has entered into a long-term strategic collaboration with Johnson & Johnson Innovation LLC* and the Lung Cancer Initiative at Johnson & Johnson to advance the development and commercialization of novel diagnostic tests to detect lung cancer at its earliest stages, when the disease is most treatable.

Kashiv Pharma, LLC, a pharmaceutical research and drug delivery company developing next-generation technologies, innovative medicines for patients with unmet medical needs and drug life-cycle management products, today announced its acquisition of the assets of Adello Biologics, LLC a biotechnology company developing biosimilars of leading global brands in the fields of oncology and immunology.

Bristol-Myers Squibb Company today announced EPS guidance for full-year 2019.

Highly Complementary Portfolios with Leading Franchises in Oncology, Immunology and Inflammation and Cardiovascular Disease

Experienced Biotech Executive to Lead Company’s Next Stage of Growth

Sojournix announced today the completion of a $44 million Series C financing.

Allergan plc today announced it intends to release fourth quarter and full year 2018 financial results on Tuesday, January 29, 2019, prior to the open of U.S. Financial Markets.

Nuvo Pharmaceuticals Inc. today announced the appointment of Rob Harris as its Executive Chairman.

Now available through Accredo, Oxervate is the first-in-class recombinant human nerve growth factor (rhNGF) and holds the potential to completely heal NK.

Provention is currently developing PRV-101 as a vaccine for acute coxsackie infection and to potentially prevent the onset of T1D